A cancer treatment similar to sac-TMT approved for marketing in China is Trodelvy (sacituzumab govitecan-hziy), developed by ...

Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan receives China NMPA marketing approval for 2L+ advanced or metastatic TNBC: Chengdu Thursday, November 28, 2024, 10:00 Hrs [IST ...

(the "Company") announced that the Company received marketing authorization in China from National Medical Products Administration (NMPA) for the first domestically developed trophoblast cell-surface ...

The blood-brain barrier is a natural membrane that protects your brain from toxins and germs.Unfortunately, this ba ...

Behold the Body. Electron microgram of a Biondi body shows a dense core surrounded by filaments that bind gold-labeled secondary antibody to TMEM239 (black dots). [Courtesy of Ghetti et al., 2024.] ...

In a study published in Cell Reports Physical Science on Nov. 25, a research team reported the development of an innovative ...

Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to ...

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced an upcoming poster presentation on ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Immune cells thereby contribute to the crosstalk between the microbiota and the brain ... You already have the perfect ...

There is a protective wall that keeps harmful substances from reaching your brain. Unfortunately, it also prevents ...

ZW191 is an antibody-drug conjugate that is engineered to target a protein called folate receptor-⍺ (FR⍺) that is found on the surface of a variety of tumors such as on ovarian, endometrial, and lung ...